Sierra, a San Francisco-based startup helping customer experience teams build AI agents, scored $350 million in new funding led by Greenoaks at a valuation of $10 billion.
Treeline Biosciences, a Watertown, Mass.-based biopharma startup currently conducting trials in patients with lymphoma, completed a $200 million Series A extension round from investors including GV and OrbiMed.
Baseten, a San Francisco-based AI inference infrastructure startup, secured $150 million in Series D funding at a $2.15 billion valuation. BOND led the round, which included participation from Greylock, CapitalG, Spark Capital and others.
Shift5, an Arlington, Va.-based operational intelligence platform for American defense and transportation systems, landed $75 million in Series C funding led by Hedosophia.
ProRataAI, a Pasadena, Calif.-based startup building AI search, advertising and attribution technology for content creators, closed a $40 million Series B round led by Touring Capital.
Hello Patient, an Austin, Texas-based provider of conversational AI technology for patient communications, collected $22.5 million in Series A funding. Scale Venture Partners led the investment, which included participation from 8VC, Bling Capital and others.
Revalia Bio, a startup providing drug developers with predictive insights from functional human organs, was seeded with a $14.5 million investment co-led by America's Frontier Fund and Sierra Ventures.
Xampla, a U.K. startup developing plant-based alternatives to single-use plastics, fetched a $14 million Series A round led by Emerald Technology Ventures.
|